The Centers for Medicare & Medicaid Services today announced four concepts that states can use to promote health coverage options under Section 1332 of the Affordable Care Act: account-based subsidies; state-specific premium assistance; adjusted plan options; and risk stabilization strategies. Specifically, the agency said the concepts allow a state to direct public subsidies into defined-contribution, consumer-directed accounts to pay for health insurance premiums or other health care expenses; design a subsidy structure that meets the unique needs of its population; provide financial assistance for different types of health insurance plans; and more flexibility to implement reinsurance programs or high-risk pools. “CMS and the Department of the Treasury look forward to engaging with states on these waiver concepts, which illustrate concepts that the Administration supports and that fit within the framework outlined in section 1332 of the Affordable Care Act,” the agency said. The departments last month issued updated guidance for states seeking to waive certain ACA requirements under Section 1332 beginning in plan year 2020. 
 

Headline
Republican leaders on the House Committee on Energy and Commerce March 5 announced they were expanding their ongoing investigation into waste, fraud and abuse…
Headline
The Centers for Medicare & Medicaid Services has released a toolkit that outlines strategies for states to strengthen access to behavioral health services…
Headline
The Centers for Medicare & Medicaid Services Feb. 25 released a request for information on potential regulatory changes in a possible future…
Headline
The AHA commented today on the Centers for Medicare & Medicaid Services’ proposed rule on the Global Benchmark for Efficient Drug Pricing Model, or…
Headline
The AHA Feb. 17 submitted a comment letter responding to the Centers for Medicare & Medicaid Services’ proposed rule that would prohibit hospitals…
Headline
The White House yesterday launched TrumpRx, the direct-to-consumer platform that will serve as a hub to direct cash-paying consumers to drug manufacturers…